La radioterapia en el tratamiento conservador del cáncer del seno
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Resumen
En trabajos anteriores propiciábamos el tratamiento conservador del cáncer del seno como la línea más racional, como garantía de la calidad asistencial, ya que mutilación no es sinónimo de curación y la extirpación contribuye a crear insatisfacción e imperfección.
Descargas
Citas
Lonning PE: Treatment of early breast cancer with conservation of the breast. A review. Act. Oncol, 1991; (30)7:779-792.
Kurtz JM, Jacquemier J: Why are local recurrences after breast-conserving therapy more frequent in younger patients? J. Clin. Oncol, 1990; (8) 4:591-598.
Fiesher B, Redmon C: Eight years results of a randomized clínical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N. Eng. J. Med, 1989; (320) 13:822-827.
Vicini FA, Eberlein TJ: The optimal extent of resection for patients with stages I or II breast cancer treated with conservative surgery ·and radiotherapy. Ann. Surg. 1991; (214) 3:200-203.
Veronesi U, Salvadori B: Conservative Treatment of early breast cancer: Long-term results of 1232 cases treated with quadrantectomy, axillary dissection and radiotherapy. Ann. Surg. 1990; (211)3: 251-259.
Fourquet A, Campana F: Prognostic factors of breast recurrence in the conservative management of early breast cancer: A 25-year follow-up. lnt. J. Rad. Oncol. Biol. Phys, 1989; 17:719-725.
McCormick B, Yahalom J: The patient perception of her breast following radiation and limited surgery. Jnt. J. Rad. Oncol-Biol. Phys., 1989; 17: 1299-1302.
Veronesi U, Luini A: Radiotherapy after breast preserving surgery in women with localized cancer of the breast. N. Eng-J.Med, 1993; (328)22: 1587-1591.
Holland L, Connolly JL: The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J. Clin. Onco/, 1990; (8)1 :113-118.
Lin PP, Allison DC: lmpact of axillary lymph node dissection on the therapy of breast cancer patients. J. Clin. Oncol 1993;(11)8: 1536-1544.
Halversan KJ, Taylor ME: Regional node management and patterns of failure following conservative surgery and radiation therapy far stage I and II breast cancer. Int.J. Rad. Oncol. Biol. Phys,1993;26:593-599.
Hoskin PJ, Rajan B:Selective avoidance of lymphatic radiotherapy in the conservative management of early breast cancer. Radiot. and Onco/., 1992;25:83-88.
The Uppsala-Orebro Breast Cancer Study Group: Sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial. JNCI, 1990;(82) 4:277-282.
Lichter AS: Conservative treatment of primarybreast cancer:How much is required? INCI, 1992; 84(9):659-661.
Kantorowitz DA, Poulter CA: Treatment of breast cancer with segmental mastectomy a/one or segmental mastectomy plus radiation. Radiot. and Oncol., 1989;15:141-150.
Recht A: Nodal treatment for patients with early stage breast cancer: guilty or innocent? Radiot. and Oncol., 1992;25:79-82.
Barte/ink H, Garavaglia G: Quality assurance in conservative treatment of early breast cancer. Radiot, and Oncol., 1991;-22:323-326.
Pierce SM, Recht A:Long-term radiation complications following conservative surgery and radiation therapy in patients with early stage breast cancer. Int. J. Rad. Onc. Biol. Phys., 1992;23:915-923.
Kurtz JM, Amalric R: Local recurrence after breast-conserving surgery and radiotherapy: frequency, time course and prognosis. Cancer, 1989;63: 1912-1917.
Haffty BG, Fischer D: Prognosis following local recurrence in the conservative/y treated breast cancer patient. Int.J. Rad-Oncol. Biol. Phys., 1991;21: 293-298.
Fowble B, So/in LJ: Frequency, sites of relapse and outcome of regional node failures following conservative surgery and radiation far early breast cancer. Int.J. Rad. Oncol. Biol-Phys, 1989; 17: 703-710.
Fisher B, Redmong C:A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with nodenegative breast cancer who have estrongen-receptor-negative tumors. N. Eng. J. Med, 1989; (320)8:473-478.
Fisher B, Costantino J: A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N. Eng. J. Med, 1989; (320)8:479-484.
The Ludwig Breast Cancer Study Group: Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for nodenegative breast cancer. N. Eng. J. Med, 1989; (320)8:491-495.
Rose MA, Henderson IC: Premenopausal breast cancer patients treated with conservative surgery, radiotherapy and adjuvant chemotherapy have a /ow risk of local failure. Int. J. Rad Oncol. Biol. Phys, 1989;17:711-717.
Blomqvist C. Tiusanen K: The combination of radio,herapy, adjuvant chemotherapy (cyclophosphamide-doxorrubicin-ftorafur) and tamoxifen in stage JI breast cancer. Long-term follow-up results of a randomized trial. Br. Cancer, 1992;66: 11 71-1176.
Mansour EG, Gray R: Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. N. Eng. J. Med, 1989; (320)8:485-490.
Rutqvist LE, Cedermark B: Radiotherapy, chemotherapy and tamoxifen as adjuncts to surgery in early breast cancer: A summary of three randomized trials. Int. J. Rad Oncol. Biol.Phys, 1989; 16:629-639.
Buchholz TA, Austin-Seymour MM: Effect of delay in radiation in the combined modality treatment of breast cancer. Int. J. Rad.Oncol. Biol. Phys, 1993; 26: 23-35.
Veronesi U, Zuca/i R: Local control and survival in early breast cancer. The Milan trial. Int.J. Rad. Oncol. Biol. Phys, 1986; 12: 717-720.
Pierquin B, Huart J: Conservative treatment for breast cancer: long-term results (15 years). Radiot.and Oncol, 1991;20:16-23.
Boyages J, Bosch C: Breast conservation: Longterm Australian data. Int. J.Rad. Oncol. Biol.Phys, 1992;24:253-260.
